Aquinox Pharmaceuticals

(NASDAQ: AQXP)
Healthcare  |  Drug Manufacturers - Specialty & Generic
2.76 0.31 12.65%
Stock Price | July 23, 2019, 3:59 p.m.
1 Follower
Bid: 0.0
Ask: 0.0
Prev. Close: 2.45
52 Week Low: 2.0
52 Week High: 3.33
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a regulator of a cellular signaling pathway in immune cells. The company's product candidate includes AQX-1125, which is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome, a chronic inflammatory disease of the bladder. All the business activity of the group is functioned through United States.

Read more Read less

Recently Viewed Tickers

Premium Stock Watchlist 05/24/2016

3 years ago

Premium Stock Watchlist 10/29/2015

3 years ago

Premium Stock Watchlist 08/07/2015

3 years ago